Unilever PLC (LSE:ULVR), Nestlé India Limited (BSE:500790) and Coca-Cola India Private Limited have begun due diligence on GlaxoSmithKline Consumer Healthcare Limited (BSE:500676) which includes Horlicks and Boost, and is estimated to be worth about $4 billion, three people aware of the developments said. Spokespersons at HUL, Nestle and Coca-Cola said they wouldnot comment on speculation'.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,312 GBX | +0.87% | +0.28% | +13.47% |
05-23 | The market is good to go until Nvidia’s next quarterly results | |
05-23 | JPMorgan Upgrades Unilever to Overweight from Underweight, Boosts PT | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.47% | 136B | |
+12.93% | 396B | |
+17.59% | 77.74B | |
-10.61% | 66.79B | |
-13.76% | 46.89B | |
-9.71% | 38.07B | |
+7.81% | 35.65B | |
+10.88% | 18.19B | |
+16.69% | 16.04B | |
+0.49% | 11.79B |
- Stock Market
- Equities
- ULVR Stock
- News Unilever PLC
- Unilever, Nestle And Coca-Cola Reportedly Begin Due Diligence On Glaxosmithkline Consumer Healthcare